Terms: = Germ cell tumor AND MYD88, Q99836, MYD88D, 4615
69 results:
1. SESN1 functions as a new tumor suppressor gene via Toll-like receptor signaling pathway in neuroblastoma.
Hua Z; Chen B; Gong B; Lin M; Ma Y; Li Z
CNS Neurosci Ther; 2024 Mar; 30(3):e14664. PubMed ID: 38516781
[TBL] [Abstract] [Full Text] [Related]
2. Sinigrin improves cerebral ischaemia-reperfusion injury by inhibiting the TLR4 pathway-mediated oxidative stress.
Guo S; Lei Q; Yang Q; Chen R
Chem Biol Drug Des; 2024 Feb; 103(2):e14480. PubMed ID: 38369620
[TBL] [Abstract] [Full Text] [Related]
3. Heterocyclic-Modified Imidazoquinoline Derivatives: Selective TLR7 Agonist Regulates tumor Microenvironment against Melanoma.
Ou J; Zheng L; Chen Y; Fu Q; Tan L; Liang E; Huang L; Pan Y; Ke J; Chen Z; Cheng K
J Med Chem; 2024 Mar; 67(5):3321-3338. PubMed ID: 38363069
[TBL] [Abstract] [Full Text] [Related]
4. CD39 and LDHA affects the prognostic role of NLR in metastatic melanoma patients treated with immunotherapy.
Mallardo D; Fordellone M; White A; Ottaviano M; Sparano F; Bailey M; Facchini AB; Ong S; Maiolino P; Caracò C; Church S; Cavalcanti E; Warren S; Budillon A; Cesano A; Simeone E; Chiodini P; Ascierto PA
J Transl Med; 2023 Sep; 21(1):610. PubMed ID: 37684649
[TBL] [Abstract] [Full Text] [Related]
5. Saikosaponin A mitigates the progression of Parkinson's disease via attenuating microglial neuroinflammation through TLR4/myd88/NF-κB pathway.
Liu XL; Fan L; Yue BH; Lou Z
Eur Rev Med Pharmacol Sci; 2023 Aug; 27(15):6956-6971. PubMed ID: 37606106
[TBL] [Abstract] [Full Text] [Related]
6. A novel immunogenic cell death signature for the prediction of prognosis and therapies in glioma.
Zhang J; Du J; Jin Z; Qian J; Xu J
PeerJ; 2023; 11():e15615. PubMed ID: 37456890
[TBL] [Abstract] [Full Text] [Related]
7.
Kim HL; Min DE; Lee SK; Choi BK; Lee DR
J Med Food; 2023 May; 26(5):328-341. PubMed ID: 37092995
[TBL] [Abstract] [Full Text] [Related]
8. A Novel Prognostic Pyroptosis-Related Gene Signature Correlates to Oxidative Stress and Immune-Related Features in Gliomas.
Zeng S; Li W; Ouyang H; Xie Y; Feng X; Huang L
Oxid Med Cell Longev; 2023; 2023():4256116. PubMed ID: 36778205
[TBL] [Abstract] [Full Text] [Related]
9. Upregulated Immunogenic cell-Death-Associated Gene Signature Predicts Reduced Responsiveness to Immune-Checkpoint-Blockade Therapy and Poor Prognosis in High-Grade Gliomas.
Tang X; Guo D; Yang X; Chen R; Jiang Q; Zeng Z; Li Y; Li Z
Cells; 2022 Nov; 11(22):. PubMed ID: 36429083
[No Abstract] [Full Text] [Related]
10. Immunogenic cell death-related risk signature predicts prognosis and characterizes the tumour microenvironment in lower-grade glioma.
Cai J; Hu Y; Ye Z; Ye L; Gao L; Wang Y; Sun Q; Tong S; Yang J; Chen Q
Front Immunol; 2022; 13():1011757. PubMed ID: 36325335
[TBL] [Abstract] [Full Text] [Related]
11. Glycoside oleandrin downregulates toll-like receptor pathway genes and associated miRNAs in human melanoma cells.
Eroğlu Güneş C; Seçer Çelik F; Seçme M; Elmas L; Dodurga Y; Kurar E
Gene; 2022 Nov; 843():146805. PubMed ID: 35964872
[TBL] [Abstract] [Full Text] [Related]
12. Costimulation of γδTCR and TLR7/8 promotes Vδ2 T-cell antitumor activity by modulating mTOR pathway and APC function.
Wang H; Chen H; Liu S; Zhang J; Lu H; Somasundaram R; Choi R; Zhang G; Ou L; Scholler J; Tian S; Dong L; Yeye G; Huang L; Connelly T; Li L; Huang A; Mitchell TC; Fan Y; June CH; Mills GB; Guo W; Herlyn M; Xu X
J Immunother Cancer; 2021 Dec; 9(12):. PubMed ID: 34937742
[TBL] [Abstract] [Full Text] [Related]
13. High accumulation of Mx2 renders limited multiplication of oncolytic herpes simplex virus-1 in human tumor cells.
Ren Y; Chen M; Wu G; Ji D; Zhou GG; Ren PG; Fu W
Sci Rep; 2021 Oct; 11(1):21227. PubMed ID: 34707174
[TBL] [Abstract] [Full Text] [Related]
14. The utility of plasma circulating cell-free messenger RNA as a biomarker of glioma: a pilot study.
Ita MI; Wang JH; Toulouse A; Lim C; Fanning N; O'Sullivan M; Nolan Y; Kaar GF; Redmond HP
Acta Neurochir (Wien); 2022 Mar; 164(3):723-735. PubMed ID: 34643804
[TBL] [Abstract] [Full Text] [Related]
15. A novel miR1983-TLR7-IFNβ circuit licenses NK cells to kill glioma cells, and is under the control of galectin-1.
Shah D; Comba A; Faisal SM; Kadiyala P; Baker GJ; Alghamri MS; Doherty R; Zamler D; Nuñez G; Castro MG; Lowenstein PR
Oncoimmunology; 2021; 10(1):1939601. PubMed ID: 34249474
[TBL] [Abstract] [Full Text] [Related]
16. Exosomal SNHG16 secreted by CSCs promotes glioma development via TLR7.
Zhang R; Li P; Lv H; Li N; Ren S; Xu W
Stem Cell Res Ther; 2021 Jun; 12(1):349. PubMed ID: 34134771
[TBL] [Abstract] [Full Text] [Related]
17. Plasma circulating cell free messenger RNA as a potential biomarker of melanoma.
Ita MI; Wang JH; Fanning N; Kaar G; Lim C; Redmond HP
Acta Oncol; 2021 Sep; 60(9):1201-1209. PubMed ID: 34086522
[TBL] [Abstract] [Full Text] [Related]
18. Palmitic acid promotes resistin-induced insulin resistance and inflammation in SH-SY5Y human neuroblastoma.
Amine H; Benomar Y; Taouis M
Sci Rep; 2021 Mar; 11(1):5427. PubMed ID: 33686181
[TBL] [Abstract] [Full Text] [Related]
19. IgM paraprotein and anti-MAG sensory polyneuropathy associated with Waldenstrom's macroglobulinaemia and medullary carcinoma of the thyroid.
Yang Y; Canepa C
BMJ Case Rep; 2021 Feb; 14(2):. PubMed ID: 33622752
[TBL] [Abstract] [Full Text] [Related]
20. A myd88/IL1R Axis Regulates PD-1 Expression on tumor-Associated Macrophages and Sustains Their Immunosuppressive Function in Melanoma.
Tartey S; Neale G; Vogel P; Malireddi RKS; Kanneganti TD
Cancer Res; 2021 May; 81(9):2358-2372. PubMed ID: 33619117
[TBL] [Abstract] [Full Text] [Related]
[Next]
